Labcorp Holdings (LH) Q1 2025 Earnings Call April 29, 2025 09:00 AM ET Company Participants Christin O'donnell - VP - Investor RelationsAdam Schechter - President, CEO & ChairmanJulia Wang - EVP & CFOLisa Gill - Managing DirectorKevin Caliendo - Managing DirectorMichael Ryskin - Managing DirectorPatrick Donnelly - Managing Director Conference Call Participants Michael Cherny - Senior Managing Director & Senior Research AnalystAnn Hynes - Senior Healthcare Services Equity Analyst & Managing DirectorErin Wrig ...

Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year: Revenue: $3.35 billion versus $3.18 billion Diluted EPS: $2.52 versus $2.69 Adjusted EPS: $3.84 versus $3.68 Reaffirmed Revenue and Free Cash Flow guidance, raised midpoint of adjusted EPS: Revenue guidance of 6.7% to 8.0% Adjusted EPS range of $15.70 to $16.40; midpoint raised $0.05 Free Cash Flow of $1.10 billion to $1.25 billion Providing broader access to comprehensive testing and laboratory ser ...

Financial Performance - In Q1 2025, the Company reported revenue of RMB 2,671 million, a decrease of 16.0% compared to RMB 3,099 million in Q1 2024 [10] - Net profit for Q1 2025 was RMB 231 million, down 32.5% from RMB 306 million in Q1 2024 [10] - Non-IFRS net profit slightly decreased by 3.1% to RMB 339 million from RMB 349 million in Q1 2024 [10] - Net operating cash flow was RMB 746 million, a decline of 14.4% from RMB 853 million in Q1 2024 [10] Revenue Composition - Revenue from China entities accounted for 88%, while overseas subsidiaries contributed 12% [12] - Laboratory services generated 60% of total revenue, followed by small molecule CDMO services at 22%, and clinical development services at 14% [12] - Revenue from the top 20 pharmaceutical customers grew by 29.1%, while revenue from other customers increased by 14.0% [12] Growth Rates - New purchase orders (POs) achieved over 10% year-on-year growth in Q1 2025 [10] - Revenue from China entities grew by 15.7%, while overseas subsidiaries saw an 18.3% increase [12] - North America revenue increased by 16.8%, and EU revenue grew by 26.6% [12] Cost and Margin Analysis - Gross margin for laboratory services improved to 45.5% in Q1 2025 from 44.1% in Q1 2024, reflecting a 1.4 percentage point increase [14] - Gross margin for small molecule CDMO services rose to 30.4%, up 2.5 percentage points from 27.9% in Q1 2024 [15] - Clinical development services in China achieved a gross margin of 11.8%, an increase of 2.5 percentage points from 9.3% in Q1 2024 [16] Future Outlook - The Company maintains a revenue growth guidance of 10-15% for 2025 [27] - Despite macroeconomic uncertainties, the Company believes in sustained industry development driven by healthcare demands and technological innovations [27]

ISSN 1564-4170 SERIES GENDER AFFAIRS 166 Effects of countercyclical policies on women's and men's incomes during the COVID-19 pandemic A gender analysis of personal taxes and transfers in Colombia, Ecuador and the Plurinational State of Bolivia Diego Collado Nicole Bidegain Thank you for your interest in this ECLAC publication Please register if you would like to receive information on our editorial products and activities. When you register, you may specify your particular areas of interest and you will ga ...

Core Viewpoint - The article emphasizes the importance of agricultural intellectual property rights (IPR) and highlights the role of South China Agricultural University in promoting and protecting these rights as a means to unlock the "invisible wealth" of agricultural products [1][4]. Group 1: Importance of Agricultural Intellectual Property - Agricultural intellectual property rights, also known as agricultural IPR, refer to the exclusive rights enjoyed by individuals or organizations over their intellectual achievements in the agricultural sector [6][7]. - These rights encompass various forms, including new plant varieties, geographical indications, agricultural patents, trademarks, copyrights, and trade secrets [7][8]. - The significance of agricultural IPR has been recognized as a strategic resource for national agricultural development and a core element in international agricultural competition [13][14]. Group 2: Initiatives by South China Agricultural University - South China Agricultural University has established a knowledge property rights research center, becoming the first university-level IPR research institution among agricultural and forestry colleges in China [20][21]. - The university has initiated the establishment of a modern seed industry IPR service center in collaboration with the Guangdong Seed Association, completing numerous agricultural patent reports annually [24][25]. - The university's variety rights authorization ranks second among agricultural and forestry universities in China, contributing to the development of first-class disciplines [26]. Group 3: Legal and Policy Contributions - The university has developed and implemented management measures for geographical indications, enhancing the legal environment for economic development in the region [30][32]. - It has also drafted support measures for modern agricultural high-quality development in Nansha District, positioning it as a national leader in seed industry support [34]. - The university's involvement in legal cases related to plant variety rights has been recognized as a typical case for judicial protection of seed industry IPR [36]. Group 4: Educational and Outreach Efforts - The university conducts various educational programs and courses related to agricultural IPR, contributing to the development of a first-class seed science and engineering program [43][44]. - It organizes forums and seminars to enhance awareness and understanding of agricultural IPR among stakeholders, including industry representatives and legal professionals [56][58]. - The university aims to support the development of an innovative economy and a brand economy in agriculture through the protection of plant variety rights and geographical indications [58][59].

Asia Value & Moat Stocks is a research service for value investors seeking Asia-listed stocks with a huge gap between price and intrinsic value, leaning towards deep value balance sheet bargains (i.e., buying assets at a discount e.g., net cash stocks, net-nets, low P/B stocks, sum-of-the-parts discounts) and wide moat stocks (i.e., buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat compounders). Sign up here to get sta ...

Core Insights - Moore Law, PLLC is investigating potential claims against OSI Systems, Inc. following a report from Culper Research that raises serious allegations about the company's financial disclosures and growth claims [1][2]. Group 1: Allegations and Investigations - Culper Research published a report on March 13, 2025, alleging that OSI's reported growth in Mexico revenues is "largely an illusion" [2]. - The report accuses OSI of downplaying U.S. Department of Justice investigations by providing "deliberately vague and misleading disclosures" [2]. - Following the report's publication, OSI's stock price fell by $6.35 per share, or 3.5%, closing at $175.31 per share on the same day [2]. Group 2: Company Background - OSI Systems, Inc. is publicly traded on NASDAQ under the ticker OSIS [1]. - Moore Law, PLLC specializes in holding corporate officers and directors accountable for various forms of corporate misconduct, including breaches of fiduciary duty and fraud [3].

有很多习惯，我们知道它对健康不利，但总会"不自觉"地放纵自己，比如熬夜、吃高热量的垃圾食品等等—— 但其实，这些坏习惯对我们健康的危害比想象中更严重。 首先，《Nature》子刊的一篇研究论文表明，一系列环境因素，包括生活方式 （例如吸烟、运动锻炼） 和生活条 件，对健康和衰老的影响比遗传因素的影响更大。 其次，睡眠作为人体最基本的生理需求之一，其质量的高低直接关系到免疫系统的功能和整体健康状态。一项 发表在《The Journal of Immunology》的研究指出，即使是短暂的一夜不睡，也会对免疫系统产生显著的负面影 响，使单核细胞的特征发生改变，进而引发慢性炎症和相关疾病的风险增加。 最后，饮食习惯对健康的影响也不容小觑。另一项发表在《Nature》子刊的研究显示，即使是短期的高热量饮 食，也会对大脑结构和功能产生长期的不良影响。 这些研究为我们提供了关于生活习惯对健康影响的有力证据，同时，它们不仅为我们敲响了警钟，也为改善健 康提供了新的方向。 生活方式的影响，远超基因 虽然人类的人均寿命已经突破了80岁，但是我们关于衰老的认知仍然在被不断颠覆——2025年2月19日，牛 津大学的研究人员在国际顶 ...

Core Insights - Solis Agrosciences has appointed Crystal Winkeler as Chief Business Officer to enhance its commercial team and drive growth initiatives [1][2] - Winkeler brings extensive experience from her previous roles, including leading investments at BioGenerator Ventures and co-founding Canopy Biosciences [2][3] - The company has shown significant progress in the AgTech sector, expanding its management team and launching new product offerings [6] Company Developments - Solis Agrosciences has secured a license for the Pairwise Fulcrum™ Platform and entered the whole-genome-sequencing market through the acquisition of Ferris Genomics [6] - The company has attracted new investments from Cultivation Capital and has significantly increased its sales [6] - Solis operates within the 39 North AgTech Innovation District in St. Louis, Missouri, focusing on high-quality AgTech research services [8][10] Leadership and Expertise - Crystal Winkeler is recognized for her ability to build business relationships and her scientific expertise, which will be beneficial for Solis [2][3] - Winkeler has a Ph.D. in Molecular Cell Biology from Washington University, adding to her qualifications [5] - Previous leadership roles include managing a team of over 40 at Canopy Biosciences and leading due diligence for seed investments at BioGenerator Ventures [3][4] Investment Landscape - Major investors in Solis include Hermann Companies, Cultivation Capital, and BioGenerator Ventures, among others [7] - Cultivation Capital is noted for being an active early-stage venture capital firm, having invested in over 150 companies since its inception [9]

Core Viewpoint - Value Line, Inc. has announced an 8.3% increase in its quarterly dividend, marking the 11th consecutive yearly increase, with the new dividend set at $0.325 per common share, payable on May 12, 2025 [1] Company Overview - Value Line is a prominent provider of investment research, with its Investment Survey being one of the most widely utilized sources of independent equity research [2] - The company publishes proprietary investment research in both print and digital formats [2] Specialized Services - Value Line Select: Monthly recommendations of one exceptional stock with superior profit potential and a favorable risk/reward ratio [3] - Value Line Special Situations Service: Monthly recommendations of small and mid-cap stocks expected to deliver returns above the market average [3] - Value Line Select ETFs: Monthly identification of one ETF positioned to outperform the market [3] - Value Line Select: Dividend Income & Growth: Monthly recommendations of two stocks expected to provide above-average current income and long-term dividend growth [4] - New Value Line ETFs Service: Analysis on over 2,800 ETFs to assist subscribers in portfolio selection [4] - Value Line M&A Service: Monthly highlight of one company as a potential acquisition target at a material premium [5] - Value Line Information You Should Know: Focuses on financial planning and investment issues relevant to today's investors [5] - Value Line Climate Change Investing Service: Targets climate change as a critical issue expected to transform the global economy [6] Research Products - Value Line Investment Survey: Provides financial information and quantitative analysis on approximately 1,800 small and mid-cap companies [8] - Value Line 600: In-depth research on 600 large and prominent companies [8] - Value Line Investment Survey–Selection & Opinion: Weekly economic and stock market commentary with actively managed model portfolios [8] - Value Line Investment Analyzer: Covers large, mid, and small-cap stocks, comprising about 90% of the U.S. stock market [10]